Literature DB >> 21073165

Speciated human high-density lipoprotein protein proximity profiles.

Kekulawalage Gauthamadasa1, Corina Rosales, Henry J Pownall, Stephen Macha, W Gray Jerome, Rong Huang, R A Gangani D Silva.   

Abstract

It is expected that the attendant structural heterogeneity of human high-density lipoprotein (HDL) complexes is a determinant of its varied metabolic functions. To determine the structural heterogeneity of HDL, we determined major apolipoprotein stoichiometry profiles in human HDL. First, HDL was separated into two main populations, with and without apolipoprotein (apo) A-II, LpA-I and LpA-I/A-II, respectively. Each main population was further separated into six individual subfractions using size exclusion chromatography (SEC). Protein proximity profiles (PPPs) of major apolipoproteins in each individual subfraction was determined by optimally cross-linking apolipoproteins within individual particles with bis(sulfosuccinimidyl) suberate (BS(3)), a bifunctional cross-linker, followed by molecular mass determination by MALDI-MS. The PPPs of LpA-I subfractions indicated that the number of apoA-I molecules increased from two to three to four with an increase in the LpA-I particle size. On the other hand, the entire population of LpA-I/A-II demonstrated the presence of only two proximal apoA-I molecules per particle, while the number of apoA-II molecules varied from one dimeric apoA-II to two and then to three. For most of the PPPs described above, an additional population that contained a single molecule of apoC-III in addition to apoA-I and/or apoA-II was detected. Upon composition analyses of individual subpopulations, LpA-I/A-II exhibited comparable proportions for total protein (∼58%), phospholipids (∼21%), total cholesterol (∼16%), triglycerides (∼5%), and free cholesterol (∼4%) across subfractions. LpA-I components, on the other hand, showed significant variability. This novel information about HDL subfractions will form a basis for an improved understanding of particle-specific functions of HDL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21073165      PMCID: PMC3006032          DOI: 10.1021/bi1015452

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  53 in total

1.  Apolipoprotein A-II modulates the binding and selective lipid uptake of reconstituted high density lipoprotein by scavenger receptor BI.

Authors:  M C de Beer; D M Durbin; L Cai; N Mirocha; A Jonas; N R Webb; F C de Beer; D R van Der Westhuyzen
Journal:  J Biol Chem       Date:  2001-02-09       Impact factor: 5.157

2.  Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells.

Authors:  Baiba K Gillard; Hu-Yu Alice Lin; John B Massey; Henry J Pownall
Journal:  Biochim Biophys Acta       Date:  2009-07-25

3.  Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase.

Authors:  M A Clay; D H Pyle; K A Rye; P J Barter
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

4.  Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography.

Authors:  Scott M Gordon; Jingyuan Deng; L Jason Lu; W Sean Davidson
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

5.  Mass spectrometric determination of apolipoprotein molecular stoichiometry in reconstituted high density lipoprotein particles.

Authors:  John B Massey; Henry J Pownall; Stephen Macha; Jamie Morris; Matthew R Tubb; R A Gangani D Silva
Journal:  J Lipid Res       Date:  2009-01-28       Impact factor: 5.922

6.  Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL.

Authors:  M A Clay; H H Newnham; T M Forte; P I Barter
Journal:  Biochim Biophys Acta       Date:  1992-02-20

7.  Surface plasmon resonance analysis of the mechanism of binding of apoA-I to high density lipoprotein particles.

Authors:  Sissel Lund-Katz; David Nguyen; Padmaja Dhanasekaran; Momoe Kono; Margaret Nickel; Hiroyuki Saito; Michael C Phillips
Journal:  J Lipid Res       Date:  2009-09-28       Impact factor: 5.922

8.  Pharmacological inhibition of ABCA1 degradation increases HDL biogenesis and exhibits antiatherogenesis.

Authors:  Reijiro Arakawa; Maki Tsujita; Noriyuki Iwamoto; Chisato Ito-Ohsumi; Rui Lu; Chen-Ai Wu; Kenji Shimizu; Tomoji Aotsuka; Hashime Kanazawa; Sumiko Abe-Dohmae; Shinji Yokoyama
Journal:  J Lipid Res       Date:  2009-05-20       Impact factor: 5.922

9.  Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function.

Authors:  W Sean Davidson; R A Gangani D Silva; Sandrine Chantepie; William R Lagor; M John Chapman; Anatol Kontush
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-26       Impact factor: 8.311

Review 10.  Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses.

Authors:  Laurent Yvan-Charvet; Nan Wang; Alan R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-01       Impact factor: 8.311

View more
  14 in total

1.  Solution structure of discoidal high-density lipoprotein particles with a shortened apolipoprotein A-I.

Authors:  Stefan Bibow; Yevhen Polyhach; Cédric Eichmann; Celestine N Chi; Julia Kowal; Stefan Albiez; Robert A McLeod; Henning Stahlberg; Gunnar Jeschke; Peter Güntert; Roland Riek
Journal:  Nat Struct Mol Biol       Date:  2016-12-26       Impact factor: 15.369

Review 2.  Speciated High-Density Lipoprotein Biogenesis and Functionality.

Authors:  C Rosales; W S Davidson; B K Gillard; A M Gotto; H J Pownall
Journal:  Curr Atheroscler Rep       Date:  2016-05       Impact factor: 5.113

Review 3.  Structural stability and functional remodeling of high-density lipoproteins.

Authors:  Olga Gursky
Journal:  FEBS Lett       Date:  2015-03-05       Impact factor: 4.124

Review 4.  New insights into the determination of HDL structure by apolipoproteins: Thematic review series: high density lipoprotein structure, function, and metabolism.

Authors:  Michael C Phillips
Journal:  J Lipid Res       Date:  2012-12-10       Impact factor: 5.922

5.  Volumetric determination of apolipoprotein stoichiometry of circulating HDL subspecies.

Authors:  Jere P Segrest; Marian C Cheung; Martin K Jones
Journal:  J Lipid Res       Date:  2013-07-23       Impact factor: 5.922

6.  MD simulations suggest important surface differences between reconstituted and circulating spherical HDL.

Authors:  Jere P Segrest; Martin K Jones; Andrea Catte
Journal:  J Lipid Res       Date:  2013-07-15       Impact factor: 5.922

7.  Role of apolipoprotein A-II in the structure and remodeling of human high-density lipoprotein (HDL): protein conformational ensemble on HDL.

Authors:  Xuan Gao; Shujun Yuan; Shobini Jayaraman; Olga Gursky
Journal:  Biochemistry       Date:  2012-06-01       Impact factor: 3.162

8.  Apolipoprotein A-II-mediated conformational changes of apolipoprotein A-I in discoidal high density lipoproteins.

Authors:  Kekulawalage Gauthamadasa; Nataraja Sarma Vaitinadin; James L Dressman; Stephen Macha; Reyn Homan; Kenneth D Greis; R A Gangani D Silva
Journal:  J Biol Chem       Date:  2012-01-10       Impact factor: 5.157

9.  Crystal structure of Δ(185-243)ApoA-I suggests a mechanistic framework for the protein adaptation to the changing lipid load in good cholesterol: from flatland to sphereland via double belt, belt buckle, double hairpin and trefoil/tetrafoil.

Authors:  Olga Gursky
Journal:  J Mol Biol       Date:  2012-10-04       Impact factor: 5.469

10.  Xanthophylls, phytosterols and pre-β1-HDL are differentially affected by fenofibrate and niacin HDL-raising in a cross-over study.

Authors:  Eric J Niesor; Kekulawalage Gauthamadasa; R A Gangani D Silva; Gabriela Suchankova; David Kallend; Helena Gylling; Bela Asztalos; Elisabetta Damonte; Simona Rossomanno; Markus Abt; W Sean Davidson; Renee Benghozi
Journal:  Lipids       Date:  2013-09-26       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.